July 22 Could Ignite a Financial Nightmare

He said “a major reckoning is coming” 3 months before 2025’s crash… his work pointed to the Covid crash 25 days before stocks bottomed… and his firm spends $8 million a year in search of the biggest declines in the stock market. Now – one man has a chilling warning for the financial system on July 22.

Tue, July 22 at 10:00AM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

The 3 Best Nasdaq Stocks to Buy in February 2024

By Ian Bezek, InvestorPlace Contributor
These three Nasdaq stocks to buy now offer solid growth prospects, favorable starting valuations, and some dividend income in one package.

Retirement Riches: 3 Stocks That Can Beat Bonds for Income

By Chris MacDonald, InvestorPlace Contributor
For income investors looking at equity alternatives to fixed income securities, here are stocks that can beat bonds to consider holding.

The 3 Most Promising Stocks to Invest in Before They Take Off

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
Sponsored by potential FED interest rate cuts, these are the top stocks to invest in before they take off later this year.

Got $1,000? These 3 Penny Stocks Can Help Turn That Into $1M

By Omor Ibne Ehsan
Searching for potential multibaggers? These high-risk, high-reward penny stocks can provide life-changing returns, albeit alongside risk.

7 F-Rated Stocks to Sell for February 2024

By Louis Navellier and the InvestorPlace Research Staff
The stock market is off to a good start and there are plenty of great names out there. So don't hold on to your F-rated stocks to sell.

The 7 Best Blue-Chip Stocks to Buy in February 2024

By Marc Guberti, InvestorPlace Contributor
Blue chip stocks offer stability and can still outperform the market. These are some of the top blue chip picks to consider.

The 3 Up-and-Coming Stocks That Could Make Your February Unforgettable

By Jeremy Flint, InvestorPlace Contributor
Finding an up-and-coming stock worth investing in is harder than it used to be, but you don't have to look far if you check out this list.

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

By Josh Enomoto, InvestorPlace Contributor
Last October, life sciences giant Thermo Fisher Scientific (NYSE:TMO) inadvertently laid out the case for contrarian biotech stocks. According to Reuters, the company revealed that…

5 Stocks to Buy to Invest Like Nvidia

By Samuel O'Brient, InvestorPlace Reporter
Do you want to invest like Nvidia? Here are the stocks to buy if you want to follow the chipmaker methodology and focus on AI exposure.

Exit Now! 3 Small-Cap Stocks to Sell in February 2024

By Matthew Farley, InvestorPlace Contributor
Discover why these three small-cap stocks to sell in February 2024, as their risks overshadow potential rewards.

3 Inflation-Proof Stock Picks Following Tuesday’s CPI Report

By Stavros Tousios, InvestorPlace Contributor
Discover the strength of inflation-proof stocks through these investment picks, as they offer attractive yields and promising growth.

The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.

By Ian Bezek, InvestorPlace Contributor
Looking for the next generational winner in healthcare stocks? These are three of the top prospects today.

The 3 Biotech Stocks That Could Make Your February Unforgettable

By Ian Cooper, InvestorPlace Contributor
After a blistering hot year of biotech M&A, we’ll see more of the same in 2024. That could be great news for these hot biotech stocks.

Nano-X Imaging (NNOX) Stock Soars 50% on Nvidia Investment

By Samuel O'Brient, InvestorPlace Reporter
Nvidia has disclosed investments in five tech companies, including Nano-X Imaging. Here's why this could signal a turnaround for NNOX stock.

7 Undervalued Dividend Stocks to Buy in February for High Total Returns

By Faisal Humayun, InvestorPlace Contributor
The undervalued dividend stocks could see serious growth before too long. Plus, they pay you to hold them while you wait.

Biden Boom: 7 Stocks to Buy if Democrats Win the Election in 2024

By Omor Ibne Ehsan
Election-proof your portfolio: these seven stocks could deliver significant gains if Biden wins the election in 2024.

ChatGPT Stock Predictions: 3 Robotics & Automation Companies the AI Bot Thinks Have 10X Potential

By Muslim Farooque, InvestorPlace Contributor
Wager on these three AI-predicted top robotics stocks to buy that are poised for explosive long-term growth ahead.

3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave

By Shane Neagle, InvestorPlace Contributor
Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation.

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

By Alex Sirois, InvestorPlace Contributor
Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.
Load More Articles